Why is Gland Pharma falling/rising?

As of 07-Aug, Gland Pharma Ltd's current price is 1,952.80, reflecting a decrease of 2.15 (-0.11%). The stock has been underperforming recently, having fallen for the last three days, resulting in a total decline of 1.43% during this period. Additionally, the stock has underperformed its sector by 0.76% today. Over the past week, Gland Pharma's performance has been notably poor, with a decline of 5.07%, while its one-month return shows a modest increase of 4.01%. Despite some positive financial results reported on June 25, including the highest net sales and profit before tax for the quarter, the stock's recent movement has been negatively influenced by falling investor participation, as evidenced by a significant drop in delivery volume.
In the broader market context, Gland Pharma's short-term performance contrasts sharply with the benchmark Sensex, which has only declined by 0.69% over the same week. While the stock has shown a year-to-date gain of 9.18%, it has underperformed the Sensex over the past year, which has seen a modest increase of 1.45%. The high institutional holdings at 40.24% suggest that knowledgeable investors are backing the company, yet the recent price decline indicates a lack of confidence among retail investors, compounded by the stock's liquidity being adequate but not robust. Overall, while there are positive fundamentals, the recent price movement reflects a combination of short-term selling pressure and reduced trading activity.